Is air pollution associated with increased incidence of myocardial infarction and cardiogenic shock?

In a recent study published in Scientific Reports, researchers from Korea explored the association between prolonged exposure to air pollution (AP) and ST-elevation myocardial infarction (STEMI) and in-hospital cardiogenic shock.

They found that exposure to particulate matter (PM) with diameter <10 µm (PM10) was associated with an elevated risk of STEMI compared to non-STEMI (NSTEMI).

Further, exposure to PM10 and sulfur dioxide (SO2) exposure were found to be associated with an increased incidence of in-hospital cardiogenic shock.

Study: Long-term air pollution exposure is associated with higher incidence of ST-elevation myocardial infarction and in-hospital cardiogenic shock. Image Credit: TR STOK/Shutterstock.comStudy: Long-term air pollution exposure is associated with higher incidence of ST-elevation myocardial infarction and in-hospital cardiogenic shock. Image Credit: TR STOK/Shutterstock.com

Background

Ischemic heart diseases (IHD), such as acute myocardial infarction (AMI), present a significant health challenge across the globe, particularly in the Asia-Pacific region.

Evidence suggests that short- and long-term exposure to AP is associated with complications in individuals with coronary artery disease (CAD), such as hospitalization, re-admission, and early death.

Although previous studies have explored the short-term impact of AP on AMI, there is limited investigation into the long-term outcomes, specifically regarding the relative occurrences of STEMI and NSTEMI, and the development of cardiogenic shock.

While STEMI typically involves total coronary artery blockage and active heart muscle damage, NSTEMI involves partial blockage with lesser heart muscle damage.

Previously, researchers found that AP exposure was linked to adverse clinical outcomes in AMI patients, in both short and long-term exposures.

In the present study, the same group of researchers build on their previous findings to investigate the potential link between long-term AP exposure, STEMI, and cardiogenic shock.

About the study

The study included participants from the Korea AMI registry (KAMIR) and KAMIR-National Institutes of Health (NIH), involving a nationwide prospective multicenter registration series to establish treatment guidelines and analyze Korean AMI patients' clinical characteristics.

The participants were enrolled from 2006 to 2015. The exclusion criteria for patients were symptom-onset before 2006, missing onset date, age < 18 years, and the absence of a diagnosis of myocardial infarction (MI) at discharge. A total of 45,619 participants were included— 20,526 with NSTEMI and 25,093 with STEMI.

Hourly AP concentrations obtained from the Korean Ministry of Environment were measured at 329 nationwide monitoring stations using various methods.

Data transformation into daily averages and calculation of annual averages before the symptom day were performed, excluding PM2.5 due to unavailability. The date of onset of MI symptoms was defined as the symptom date.

AMI diagnosis involved elevated cardiac biomarkers, typical electrocardiogram (ECG) changes, and clinical symptoms, with STEMI identified by new ST-elevation ≥ 1 mm in ≥ 2 contiguous leads.

NSTEMI patients exhibited positive biomarkers without STEMI ECG findings. Cardiogenic shock was defined by low blood pressure, requiring support to maintain it, and signs of pulmonary congestion. Its complication was considered if it occurred post-admission.

Information on various cardiovascular risk factors (diabetes mellitus, family history of CAD, hypertension, dyslipidemia, prior cardiovascular disease, heart failure, prior cerebrovascular disease (CVA), and smoking) was self-reported by the patients.

Statistical analysis involved the use of chi-square test, Fisher’s exact test, Student’s t-test, Mann–Whitney rank test, Kolmogorov-Smirnov test, generalized logistic mixed effect models, correlation analysis, variance inflation factor, odds ratios (OR), logistic regression, and subgroup analysis.

Results and discussion

Compared to NSTEMI patients, STEMI patients were younger, predominantly male, had higher smoking rates, fewer underlying chronic conditions, and presented with more severe angiographic and clinical features, including a higher rate of cardiogenic shock complications during the index hospitalization.

PM10 showed a significant association with increased STEMI incidence (OR 1.009), and both PM10 and SO2 were linked to higher risks of in-hospital cardiogenic shock complications (OR 1.03 and 1.104, respectively).

Conversely, increase in O3 was negatively correlated with cardiogenic shock (OR 0.891). Subgroup analysis showed a significant association between a decrease in STEMI incidence and an increase in NO2 among CVA patients.

The study emphasizes the role of minimizing exposure to elevated AP levels in reducing MI risk and mortality across high and low-risk groups.

However, the findings are limited by the study design, limited sampling data for PM2.5, restricting associations with clinical events, lack of PM2.5 data for years preceding 2015, potential misclassification of patient exposure, and the potential for variations and input errors in the multicenter registry data, emphasizing the need for cautious interpretation.

Conclusion

In conclusion, the present study suggests that elevated concentrations of air pollutants, especially PM10, pose an environmental risk and are linked to an increased occurrence of STEMI.

Additionally, both PM10 and SO2 levels are identified as risk factors for the complication of in-hospital cardiogenic shock following MI.

The findings highlight the urgent need for implementing policy-level strategies and clinical interventions to mitigate AP exposure, potentially preventing STEMI and reducing the risk of severe cardiovascular complications for improved public health outcomes.

Journal reference:
Dr. Sushama R. Chaphalkar

Written by

Dr. Sushama R. Chaphalkar

Dr. Sushama R. Chaphalkar is a senior researcher and academician based in Pune, India. She holds a PhD in Microbiology and comes with vast experience in research and education in Biotechnology. In her illustrious career spanning three decades and a half, she held prominent leadership positions in academia and industry. As the Founder-Director of a renowned Biotechnology institute, she worked extensively on high-end research projects of industrial significance, fostering a stronger bond between industry and academia.  

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chaphalkar, Sushama R.. (2024, March 04). Is air pollution associated with increased incidence of myocardial infarction and cardiogenic shock?. News-Medical. Retrieved on October 13, 2024 from https://www.news-medical.net/news/20240304/Is-air-pollution-associated-with-increased-incidence-of-myocardial-infarction-and-cardiogenic-shock.aspx.

  • MLA

    Chaphalkar, Sushama R.. "Is air pollution associated with increased incidence of myocardial infarction and cardiogenic shock?". News-Medical. 13 October 2024. <https://www.news-medical.net/news/20240304/Is-air-pollution-associated-with-increased-incidence-of-myocardial-infarction-and-cardiogenic-shock.aspx>.

  • Chicago

    Chaphalkar, Sushama R.. "Is air pollution associated with increased incidence of myocardial infarction and cardiogenic shock?". News-Medical. https://www.news-medical.net/news/20240304/Is-air-pollution-associated-with-increased-incidence-of-myocardial-infarction-and-cardiogenic-shock.aspx. (accessed October 13, 2024).

  • Harvard

    Chaphalkar, Sushama R.. 2024. Is air pollution associated with increased incidence of myocardial infarction and cardiogenic shock?. News-Medical, viewed 13 October 2024, https://www.news-medical.net/news/20240304/Is-air-pollution-associated-with-increased-incidence-of-myocardial-infarction-and-cardiogenic-shock.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
FIRS urges global leaders to combat air pollution and lung disease